KANGMEI PHARMACEUTICAL CO., LTD.

Insiders Kangmei Pharmaceutical Co., Ltd.

Equities

600518

CNE0000017M1

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
1.85 ^CNY	-0.54%		-3.14%	-0.54%

Apr. 30	Kangmei Pharmaceutical Logs Profit in Q1	MT
Apr. 29	Kangmei Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kangmei Fraud Case Decision Triggers Exodus of Independent Directors From Listed Firms	21-11-21	MT
Kangmei Pharmaceutical Co., Ltd. Appoints Zhou Yunfeng as Secretary to Directorate	21-02-18	CI
Kangmei Pharmaceutical Co., Ltd. Approves Appointment of Gong Guibo as Deputy General Manager	20-10-11	CI
Kangmei Pharmaceutical Co., Ltd. Approves Appointment of Liu Guowei as General Manager	20-10-11	CI
Kangmei Pharmaceutical Co., Ltd. Appoints Ma Xinggu Chair as Directorate	20-06-18	CI
China's securities watchdog pledges to clean up financial markets	20-05-15	RE
Kangmei Pharmaceutical Co., Ltd. Announces Executive Appointments	19-10-22	CI
Kangmei Pharmaceutical Co., Ltd. Announces Board Elections; Approves Cash Dividend for the Year 2014	15-06-03	CI
Kangmei Pharmaceutical Co., Ltd. Elects Zhang Hong as Independent Director; Plans to Invest RMB 3 Billion in Constructing China - Asean Kangmei Yulin Herbs Trading Center and Modern Logistics and Warehousing Projects	14-04-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer